Download Image
    
Share
  
Post
Sentinox for COVID-19
1 study with 57 patients
Hospital Icon Control Serious Outcome Risk
Hospital Icon Sentinox
Significantly lower risk for viral clearance.
COVID-19 Sentinox studies. Dec 2025. c19early.org
0 0.5 1 1.5+ All studies 67% Viral clearance 29% RCTs 67% Early 67% Favorssentinox Favorscontrol
May 12
2022
 Panatto et al., Viruses, doi:10.3390/v14051033 Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study
67% lower progression (p=0.32) and 29% improved viral clearance (p=0.01). RCT 57 mild COVID-19 patients showing non-significant viral load reduction with Sentinox (STX), a hypochlorous acid nasal spray. The proportion of COVID negative patients by day 5 was significantly higher in the STX-3 group than controls...